The last 20 actions on file set price targets from $22.00 to $38.00, averaging $30.00.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 28 Sep 2026 | RBC Capital | HOLD | $26.00 |
| 24 Sep 2026 | UBS | BUY | $36.00 |
| 18 Sep 2026 | Morgan Stanley | HOLD | $32.00 |
| 21 Aug 2026 | Argus Research | BUY | $32.00 |
| 7 Aug 2026 | Wells Fargo | HOLD | $28.00 |
| 7 Aug 2026 | UBS | BUY | $36.00 |
| 7 Aug 2026 | Morgan Stanley | HOLD | $32.00 |
| 7 Aug 2026 | Evercore | BUY | – |
| 7 Aug 2026 | Barclays | HOLD | $32.00 |
| 7 Aug 2026 | RBC Capital | HOLD | $30.00 |
| 16 Jul 2026 | RBC Capital | HOLD | $27.00 |
| 13 Jul 2026 | Wells Fargo | HOLD | $30.00 |
| 28 Jun 2026 | Wells Fargo | HOLD | $30.00 |
| 14 Jun 2026 | Wells Fargo | HOLD | $30.00 |
| 21 May 2026 | Argus Research | BUY | $32.00 |
| 8 May 2026 | Wells Fargo | HOLD | $22.00 |
| 8 May 2026 | Evercore | BUY | $38.00 |
| 8 May 2026 | Barclays | HOLD | $27.00 |
| 8 May 2026 | RBC Capital | HOLD | $24.00 |
| 5 May 2026 | Barclays | HOLD | $26.00 |
No comments yet — be the first to weigh in on GEN.